Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)

Donato Rigante, Antonio Vitale, Giacomo Emmi, Giuseppe Lopalco, Claudia Fabiani, Stefano Gentileschi, Elena Silvestri, Gerardo Di Scala, Florenzo Iannone, Bruno Frediani, Mauro Galeazzi, Giovanni Lapadula, Luca Cantarini

Research output: Contribution to journalArticle

Abstract

A correction is reported in comparison with the original version of the paper.
Original languageEnglish
Pages (from-to)267-267
Number of pages1
JournalCLINICAL RHEUMATOLOGY
Volume38
DOIs
Publication statusPublished - 2019

Keywords

  • Behçet's disease

Fingerprint

Dive into the research topics of 'Correction to: Long-term efficacy and safety of golimumab in the treatment of multirefractory Behçet’s disease (Clinical Rheumatology, (2017), 36, 9, (2063-2069), 10.1007/s10067-017-3627-4)'. Together they form a unique fingerprint.

Cite this